Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Investigations of the biosynthesis of sparsomycin

Thesis/Dissertation ·
OSTI ID:5228050
Investigations of the biosynthesis of the antitumor antibiotic sparsomycin (1) by Streptomyces sparsogenes have been carried out. Incorporation studies employing ({sup 13}C)-labeled precursors have shown that the monoxodithioacetal moiety (6) of the antibiotic arises from the stepwise introduction of a thiomethyl group into the S-methyl group of S-methyl-D-cysteine. The methyl group of (6) has its origin in the methyl group of L-methionine, but an experiment utilizing (methyl-{sup 3}H,{sup 35}S)-L-methionine has demonstrated that intact incorporation of the thiomethyl group of this precursor does not occur. The results of feeding experiments with ({sup 13}C)- and ({sup 2}H)-labeled forms of tryptophan have indicated that the uracil moiety (7) of sparsomycin is derived from the indole nucleus of tryptophan via aromatic ring cleavage followed by recyclization. Preliminary evidence for the intermediacy of N-formyl-anthranilic acid in the conversion of tryptophan to sparsomycin has been obtained.
Research Organization:
Rice Univ., Houston, TX (USA)
OSTI ID:
5228050
Country of Publication:
United States
Language:
English